Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 1/2000

01-03-2000

Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast

Authors: Goro Amano, Noriaki Ohuchi, Tadashi Ishibashi, Takanori Ishida, Masakazu Amari, Susumu Satomi

Published in: Breast Cancer Research and Treatment | Issue 1/2000

Login to get access
Metadata
Title
Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast
Authors
Goro Amano
Noriaki Ohuchi
Tadashi Ishibashi
Takanori Ishida
Masakazu Amari
Susumu Satomi
Publication date
01-03-2000
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 1/2000
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006342711426

Other articles of this Issue 1/2000

Breast Cancer Research and Treatment 1/2000 Go to the issue

OriginalPaper

Antagonists of growth hormone-releasing hormone arrest the growth of MDA-MB-468 estrogen-independent human breast cancers in nude mice

OriginalPaper

Is ICI 182,780 an antiprogestin in addition to being an antiestrogen?

OriginalPaper

Detection of microsatellite alterations in nipple discharge accompanied by breast cancer

OriginalPaper

Resection margin status in lumpectomy specimens of infiltrating lobular carcinoma

OriginalPaper

Framing of outcome and probability of recurrence: Breast cancer patients' choice of adjuvant chemotherapy (ACT) in hypothetical patient scenarios

OriginalPaper

Progression in MCF-7 breast cancer cell tumorigenicity: compared effect of FGF-3 and FGF-4
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits